Internet Archive Scholar

OP0026 Adalimumab serum concentration fails to predict achievement of sustained remission or absence of flare for patients with non-radiographic axial spondyloarthritis in the ability-3 study

N.V. Kwatra, M. Magrey, P.J. Mease, J. Sieper, R. Landewe, X. Wang, A. Lertratanakul, J.K. Anderson, N.M. Mostafa
2018 WEDNESDAY, 13 JUNE 2018   unpublished

Preserved Fulltext

fulltext thumbnail
Web Archive Capture PDF (236.4 kB)
https://web.archive.org/web/20190502051838/https://ard.bmj.com/content/annrheumdis/77/Suppl_2/63.1.full.pdf

A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL. The file type is application/pdf.

Conclusions: Long-term therapy with a TNF blocker seems to decelerate progression of structural damage in the SIJ. Elevated CRP and presence of osteitis in MRI were independently associated with SIJ radiographic progression. REFERENCE: [1] Song IH, et al. Ann Rheum Dis 2011;70(4):590-596.
doi:10.1136/annrheumdis-2018-eular.6515 fatcat:pbzb5bt7lney5eop7wcgdo6ojy
Citation

N.V. Kwatra, M. Magrey, P.J. Mease, J. Sieper, R. Landewe, X. Wang, A. Lertratanakul, J.K. Anderson, N.M. Mostafa. "OP0026 Adalimumab serum concentration fails to predict achievement of sustained remission or absence of flare for patients with non-radiographic axial spondyloarthritis in the ability-3 study." WEDNESDAY, 13 JUNE 2018 (2018)